“Immune Modulation Unpacked: The Science of Thymosin Alpha-1”
From Today's discussion on unraveling BPC 157 Peptide by Infinity Peptides
January 12, 2026 · 38 min · Episode 60
About this episode
This episode provides an evidence-based breakdown of Thymosin Alpha-1, focusing on its immune mechanisms and research findings.
An evidence-based breakdown of Thymosin Alpha-1 (TA-1) covering immune mechanisms, preclinical research, human clinical trials, safety data, and ongoing studies in infection, sepsis, and cancer.
People in this episode
Host: Infinity Peptides
Topics covered
- immune modulation
- Thymosin Alpha-1
- clinical trials
- safety data
- preclinical research
Keywords
- Thymosin Alpha-1
- immune mechanisms
- clinical trials
- safety data
- preclinical research
Mentioned in this episode
Products: Thymosin Alpha-1
More episodes of Today's discussion on unraveling BPC 157 Peptide
- The secret Hollywood stack · June 5, 2026 · 23 min
- Selank: The Russian Peptide for Calm Focus and Neuroplasticity · May 29, 2026 · 19 min
- MOTS-c, a unique peptide encoded within mitochondrial DNA · May 25, 2026 · 19 min
- SS-31 and the Architecture of Mitochondrial Medicine · March 9, 2026 · 20 min
- Snap-8 Science: A Deep Dive into Peptide Power · February 12, 2026 · 14 min
- FST-344: Scientific Foundations and Therapeutic Potential · February 2, 2026 · 17 min
Explore listener stats, chart rankings, contacts and more on the Today's discussion on unraveling BPC 157 Peptide podcast page.